 |
|
|
| |
Safety, pharmacokinetic, pharmacodynamics and viral data after 6-weeks of dosing with TLR7 agonist RO7020531 in chronic hepatitis B patients
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Man-Fung Yuen1, RozalinaBalabanska2, KoshAgarwal3, YonghongZhu4, Joseph F. Grippo5, YuyanJin4, QiudiJiang4, Miriam Triyatni6, RuchiUpmanyu7, Katerina Glavini6, Tomas Racek6, Edward J. Gane8
1Queen Mary Hospital, Hong Kong; 2. AcibademCity Clinic, TokudaHospital, Sofia; 3. Institute of Liver Studies, Kings College Hospital, London; 4. Roche Innovation Center Shanghai 5. Roche Innovation Center New York; 6. Roche Innovation Center Basel; 7. Roche Innovation Center Welwyn; 8. Auckland Clinical Studies
|
| |
|
|
|
|
|
